Physician profile
Andrew David Lacombe
NPI 1033642095
$51,657.92
in general payments reported to CMS, 2019-2025
7 companies · $3,908 in 2025
The $3,908 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $7,548 · 2024: $40K · 2025: $3,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $46K · Food and Beverage: $2,803 · Travel and Lodging: $2,428 · Education: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $46,000.01 |
| Food and Beverage | $2,803.08 |
| Travel and Lodging | $2,428.46 |
| Education | $426.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26,026.50 | 2023-2025 | Tacticath Ablation Catheter, Sensor Enabled, Assurity, Ensite |
| Medtronic, INC. | $19,924.73 | 2023-2025 | Affera Mapping System, Micra, Linq II |
| Boston Scientific Corporation | $5,211.95 | 2024-2025 | Acuity Steerable, Emblem Mri S-Icd |
| Biosense Webster, INC. | $259.93 | 2024-2025 | Carto 3 |
| Philips North America LLC | $215.94 | 2024-2025 | (Ao0) Igt Devices Intracardiac, Igt Devices Undivided |
| Cordis US Corp. | $18.87 | 2025 | Mynx Control Venous |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lacombe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.